PBE vs. FBT
PBE (Invesco Dynamic Biotechnology & Genome ETF) and FBT (First Trust Amex Biotechnology Index) are both Health & Biotech Equities funds - PBE tracks the Dynamic Biotech & Genome Intellidex Index (AMEX) while FBT tracks the NYSE Arca Biotechnology Index. Both are passively managed. Over the past 10 years, PBE returned 7.34%/yr vs 8.55%/yr for FBT. Their correlation of 0.89 suggests significant overlap in exposure. PBE charges 0.59%/yr vs 0.57%/yr for FBT.
Performance
PBE vs. FBT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBE achieves a -1.43% return, which is significantly lower than FBT's 4.04% return. Over the past 10 years, PBE has underperformed FBT with an annualized return of 7.34%, while FBT has yielded a comparatively higher 8.55% annualized return.
PBE
- 1D
- -2.22%
- 1M
- 1.51%
- YTD
- -1.43%
- 6M
- -0.16%
- 1Y
- 28.65%
- 3Y*
- 9.70%
- 5Y*
- 2.89%
- 10Y*
- 7.34%
FBT
- 1D
- -2.55%
- 1M
- 4.52%
- YTD
- 4.04%
- 6M
- 2.25%
- 1Y
- 32.73%
- 3Y*
- 11.32%
- 5Y*
- 6.32%
- 10Y*
- 8.55%
PBE vs. FBT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | -1.43% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
FBT First Trust Amex Biotechnology Index | 4.04% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
Correlation
The correlation between PBE and FBT is 0.90, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.90 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.88 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.90 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.90 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2006 | 0.89 |
The correlation between PBE and FBT has been stable across timeframes, ranging from 0.88 to 0.90 - a consistent structural relationship.
PBE vs. FBT - Sectors Allocation Comparison
Sectors
PBE
FBT
Healthcare
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PBE
FBT
Financial Services
PBE
FBT
-
Basic Materials
PBE
-
FBT
-
Communication Services
PBE
-
FBT
-
Consumer Cyclical
PBE
-
FBT
-
Consumer Defensive
PBE
-
FBT
-
Energy
PBE
-
FBT
-
Industrials
PBE
-
FBT
-
Real Estate
PBE
-
FBT
-
Technology
PBE
-
FBT
-
Utilities
PBE
-
FBT
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBE vs. FBT — Risk / Return Rank
PBE
FBT
PBE vs. FBT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and First Trust Amex Biotechnology Index (FBT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PBE | FBT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.55 | 1.60 | -0.05 |
Sortino ratioReturn per unit of downside risk | 2.33 | 2.37 | -0.04 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.28 | -0.01 |
Calmar ratioReturn relative to maximum drawdown | 2.62 | 2.33 | +0.29 |
Martin ratioReturn relative to average drawdown | 7.37 | 6.85 | +0.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PBE | FBT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.55 | 1.60 | -0.05 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.13 | 0.29 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.30 | 0.36 | -0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.51 | -0.19 |
Drawdowns
PBE vs. FBT - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, which is greater than FBT's maximum drawdown of -40.51%. Use the drawdown chart below to compare losses from any high point for PBE and FBT.
Loading charts...
Drawdown Indicators
| PBE | FBT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -40.51% | -5.18% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -14.26% | +2.53% |
Max Drawdown (3Y)Largest decline over 3 years | -22.43% | -20.05% | -2.38% |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | -29.05% | -5.66% |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | -32.37% | -5.47% |
Current DrawdownCurrent decline from peak | -5.55% | -3.54% | -2.01% |
Average DrawdownAverage peak-to-trough decline | -16.24% | -11.17% | -5.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.17% | 4.85% | -0.68% |
Volatility
PBE vs. FBT - Volatility Comparison
The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 5.33%, while First Trust Amex Biotechnology Index (FBT) has a volatility of 6.48%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than FBT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PBE | FBT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.33% | 6.48% | -1.15% |
Volatility (6M)Calculated over the trailing 6-month period | 13.30% | 15.76% | -2.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.67% | 20.60% | -1.93% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.52% | 21.85% | +0.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.91% | 23.90% | +1.01% |
PBE vs. FBT - Expense Ratio Comparison
PBE has a 0.59% expense ratio, which is higher than FBT's 0.57% expense ratio.
Dividends
PBE vs. FBT - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.07%, while FBT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.07% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
PBE and FBT have a correlation of 0.90, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FBT has higher volatility (6.48%) compared to PBE (5.33%). In terms of maximum drawdown, PBE dropped -45.69% vs FBT's -40.51%.
On 10-year performance, FBT leads with 8.55% vs 7.34% for PBE. On fees, FBT is cheaper at 0.57% per year. On volatility, PBE has been the lower-risk option at 5.33%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FBT has performed better with a 8.55% return vs 7.34%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FBT is cheaper with a 0.57% expense ratio, compared with 0.59% for PBE.
PBE has the higher dividend yield at 1.07%, compared with 0.00% for FBT.
PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while FBT tracks NYSE Arca Biotechnology Index. They also come from different issuers: Invesco and First Trust. Their fees differ too: 0.59% for PBE and 0.57% for FBT.
FBT currently has the higher Sharpe Ratio (1.60 vs 1.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PBE and FBT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer